Sponsor or institution
Clinical trials and research at French Innovative Leukemia Organisation
As of November 12, 2026, Find a Trial lists 6 clinical trials run by French Innovative Leukemia Organisation that are recruiting, in France. By phase: Phase 2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Tagraxofusp and venetoclax in newly diagnosed BPDCN | Phase 2 | Amiens and 33 other locations | Recruiting | Jun 5, 2025 |
| Observational study of older patients with acute myeloid leukemia receiving intensive treatment | — | Angers and 26 other locations | Recruiting | Mar 24, 2025 |
| Observational study on the use of Ivosidenib for patients with Acute Myeloid Leukemia in France | — | Amiens and 20 other locations | Recruiting | Apr 22, 2024 |
| Treatment for Richter Syndrome using Glofitamab with Rituximab or Obinutuzumab plus CHOP | Phase 2 | Amiens and 22 other locations | Recruiting | Jan 2, 2024 |
| Combining oral azacitidine with gilteritinib for treating relapsed FLT3-mutated acute myeloid leukemia | Phase 2 | Amiens and 19 other locations | Recruiting | Sep 1, 2023 |
| Prognostic analysis for patients with Waldenström's Disease | — | Amiens and 14 other locations | Recruiting | Jun 22, 2023 |
All recruiting trials (6)
-
Tagraxofusp and venetoclax in newly diagnosed BPDCN
This trial tests whether combining tagraxofusp with venetoclax can produce higher complete remissions in adults with newly diagnosed BPDCN.
-
Observational study of older patients with acute myeloid leukemia receiving intensive treatment
This study looks at older patients with acute myeloid leukemia to see how well intensive treatment works for them and what factors might affect their recovery and survival.
-
Observational study on the use of Ivosidenib for patients with Acute Myeloid Leukemia in France
This study looks at how well a drug called Ivosidenib works for people in France with acute myeloid leukemia who have a specific gene mutation, to see if it helps them feel better or respond to treatment.
-
Treatment for Richter Syndrome using Glofitamab with Rituximab or Obinutuzumab plus CHOP
This study is testing if a new treatment combining Glofitamab with Rituximab or Obinutuzumab and CHOP chemotherapy can help people with untreated Richter Syndrome feel better.
-
Combining oral azacitidine with gilteritinib for treating relapsed FLT3-mutated acute myeloid leukemia
This study is testing if adding an oral medication called azacitidine to gilteritinib can help adults with relapsed FLT3-mutated acute myeloid leukemia feel better and live longer.
-
Prognostic analysis for patients with Waldenström's Disease
This study looks at patients with Waldenström's Disease to see if certain blood tests can help predict how their condition will progress and how they will respond to treatment.
Quick answers
How many clinical trials run by French Innovative Leukemia Organisation are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in France. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.